A company still losing money with steady sales. Institutions are trimming.
Going well
Sales growth speeding up
Watch out for
Losing money, losses are large next to sales
Money moves
No insider buying or selling in the last 30 days
Institutions cut 17% from their holdings in the quarter ending June 2026 (56 bought, 60 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$1.95+7.1% that day
Company value
$84M
Share price times all shares
Price vs sales
0.96x
No profit over the last year, so this compares value with sales instead
Cash vs value
67%
A big cushion: cash is a large part of what the company is worth
Debt vs value
44%
Debt as a share of company value
From LUNG's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$22.8M-4.6% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $87.4M, down 3.4% from the 12 months before. Over 5 years, sales grew about 23% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of LUNG. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$75M
Profit in 5 years$8M
Price these guesses point to$2.26+16% vs $1.95 todayAbout +3.0% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 5.8% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.